{"article_title": "Is Buffett Abandoning Health-Care Stocks? -- The Motley Fool", "article_keywords": ["fool", "million", "stocks", "pharma", "johnson", "motley", "industry", "buffett", "buffetts", "investing", "health", "investors", "healthcare", "position", "abandoning", "warren"], "article_url": "http://www.fool.com/investing/general/2014/02/22/is-buffett-abandoning-healthcare-stocks.aspx", "article_text": "Warren Buffett's Berkshire Hathaway (NYSE:BRK-B) just disclosed in a fourth-quarter filing that it has liquidated its position in big pharma stock GlaxoSmithKline (NYSE:GSK). Does that mean Buffett is abandoning the health-care industry? Should investors follow the Oracle of Omaha's lead and dump their pharma and biotech holdings?\n\nIn one word: No!\n\nTaking a closer look at the 13F filing reveals Berkshire has not abandoned the industry. It still has a $30 million position in Johnson & Johnson, and $210 million stake in Sanofi, and is the largest single shareholder of DaVita. Buffett aggressively accumulated shares in the dialysis service provider last year, which are currently valued at $2.3 billion.\n\nIn this segment of The Motley Fool's health care-focused investing show Market Checkup, analyst David Williamson discusses what Buffett's decision to dump Glaxo means, dives in to the remaining health care holdings in Berkshire's portfolio, and highlights different strategies investors can take to profit from Warren Buffett's investing acumen.", "article_metadata": {"publish_time": "13:05", "date": "2014-02-22T18:05:00Z", "description": "Could Warren Buffett be exiting his positions in the health care sector?", "ResponsiveALP": "1Ses_2things-v-single_2-things_50", "author": "Dave Williamson", "promo": "Could Warren Buffett be exiting his positions in the health care sector?", "twitter": {"site": "@themotleyfool", "description": "Could Warren Buffett be exiting his positions in the health care sector?", "title": "Is Buffett Abandoning Health-Care Stocks? --  The Motley Fool"}, "og": {"site_name": "The Motley Fool", "description": "Could Warren Buffett be exiting his positions in the health care sector?", "title": "Is Buffett Abandoning Health-Care Stocks? --  The Motley Fool", "url": "http://www.fool.com/investing/general/2014/02/22/is-buffett-abandoning-healthcare-stocks.aspx", "image": "https://g.foolcdn.com/image/?url=http%3A%2F%2Fg.foolcdn.com%2Fassets%2Fimages%2Ffool%2Ftmf-logo.png&h=630&w=1200&op=resize", "type": "article"}, "headline": "Is Buffett Abandoning Health-Care Stocks?", "fb": {"admins": 50808187550, "page_id": 7240312795, "app_id": 50808187550}, "bureau": "usmf-health-care", "STORY_UID": "34347028-99bc-11e3-b358-0050569d4be0", "pitch": 360, "msvalidate.01": "8D40D58712924715BAA79D135A6C8DDA", "gsa_date": "2014 02 22", "tickers": "GSK,SNY,BRK-B,DVA", "viewport": "width=device-width, initial-scale=1.0, maximum-scale=1.0"}, "article_summary": "It still has a $30 million position in Johnson & Johnson, and $210 million stake in Sanofi, and is the largest single shareholder of DaVita.\nWarren Buffett's Berkshire Hathaway (NYSE:BRK-B) just disclosed in a fourth-quarter filing that it has liquidated its position in big pharma stock GlaxoSmithKline (NYSE:GSK).\nDoes that mean Buffett is abandoning the health-care industry?\nBuffett aggressively accumulated shares in the dialysis service provider last year, which are currently valued at $2.3 billion.\nShould investors follow the Oracle of Omaha's lead and dump their pharma and biotech holdings?"}